This inventor holds 1 USPTO granted patent. Top assignee: Instituto Butantan. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations in Immunology: The Contributions of Jean Gabriel De Souza
Introduction
Jean Gabriel De Souza is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the fields of pharmaceutical sciences and immunology. His work focuses on developing innovative methods for treating cancer through the modulation of innate immune pathways.
Latest Patents
De Souza holds a patent for a compound designed to modulate RLR, TLR, OAS, and/or oncostatin M pathways. This invention is particularly relevant for preparing medicines and pharmaceutical compositions aimed at treating cancer. The compound, derived from amblyomin-X or its peptides, offers a novel approach to enhancing immune responses against cancer.
Career Highlights
De Souza is affiliated with the Instituto Butantan, a prominent research institution in Brazil. His work at this institute has allowed him to explore groundbreaking research in immunology and cancer treatment. His patent reflects his commitment to advancing medical science and improving therapeutic options for patients.
Collaborations
De Souza has collaborated with esteemed colleagues such as Ana Marisa Chudzinski Tavassi and Roger Chammas. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Jean Gabriel De Souza's contributions to immunology and cancer treatment through his innovative patent exemplify the importance of research and collaboration in advancing medical science. His work continues to inspire future developments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile